← All research updates

Tiny radioactive beads for glioma that has come back

Original title: Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

How far along is this research?

This is a trial that is enrolling or has been updated. It is not a finding yet.

This is an early first test of the treatment in people.

Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.

The trial team last updated this record on . Always check the trial page for the latest.

The short version

This study is testing whether tiny radioactive beads, placed in the blood vessels that feed a brain tumor, can treat it safely.

Who this trial is for. This trial is for people whose glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary has come back. It tests putting tiny radioactive beads into the blood vessels that feed the tumor. The beads give off radiation inside the tumor to try to stop it from growing.

Where it stands. This trial has not reported results. It is looking at whether this treatment can be given safely in the brain. It is also looking at how well it works. Those answers are not in yet.

What this means, and what it doesn't

What it could mean: This kind of bead treatment is already used for liver cancer. This study is an early look at using it in the brain instead. If your glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary has come back, you could ask your care team about it.

What it doesn't mean: This does not mean the treatment works in the brain. A trial is a test, not a proven treatment. Being in one is not a guarantee that it will help you. It is not a promise of a cure.

Source: ClinicalTrials.gov, July 17, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary